Fortunato Ciardiello
A.O.U. dell'Università degli studi della Campania "Luigi Vanvitelli" · University of Campania Luigi Vanvitelli · Università della Campania L Vanvitelli
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Fortunato Ciardiello as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:43 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07389265 · Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal CancerUniversity of Campania Luigi Vanvitelli · recruiting · Metastatic Colorectal Cancer (mCRC) · principal investigator
- Ph2NCT05468892 · Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO TrialUniversity of Campania Luigi Vanvitelli · completed · Metastatic Colon Cancer · principal investigator
- Ph2NCT05312398 · CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment RegimenUniversity of Campania Luigi Vanvitelli · active not recruiting · Metastatic Colorectal Adenocarcinoma · principal investigator
- Ph2NCT05291156 · CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge StrategyUniversity of Campania Luigi Vanvitelli · unknown · Metastatic Colorectal Cancer · principal investigator
- Ph3NCT05223673 · Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal CancerInstitut de Recherches Internationales Servier · terminated · Metastatic Colorectal Cancer · principal investigator
- Ph2NCT04561336 · Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal CancerUniversity of Campania Luigi Vanvitelli · completed · Metastatic Colorectal Cancer, RAS Wild Type · principal investigator
- Ph3NCT00349219 · TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung CancerNational Cancer Institute, Naples · completed · Advanced Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT00330746 · CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung CancerNational Cancer Institute, Naples · completed · Advanced Non-Small Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in colorectal cancer, ranked by citations from NIH iCite, fetched 2026-11-12 12:43 UTC. The ranking covers the 200 most relevant of 55 PubMed records, and a shared surname and initials can bring in a namesake. All 55 on PubMed
- 1,539 citationsRCR 39.3
- 1,198 citationsRCR 43.0
- 821 citationsRCR 25.4
- Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer.J Clin Oncol · 2015677 citationsRCR 20.1
- 489 citationsRCR 16.4
- 454 citationsRCR 23.9
- 446 citationsRCR 11.5
- Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.N Engl J Med · 2023391 citationsRCR 33.6
- Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial.Lancet Oncol · 2021363 citationsRCR 18.0
- Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.Mod Pathol · 2015268 citationsRCR 7.7